Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03556839
Title Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix (BEATcc)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Cancer de Ovario
Indications

cervical adenosquamous carcinoma

cervical squamous cell carcinoma

cervical adenocarcinoma

Therapies

Atezolizumab + Bevacizumab + Cisplatin + Paclitaxel

Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Cisplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.